Furthermore, the immune subtype had more tumor-infiltrating lymphocytes (TILs) especially CD8+ and activated CD4 + T cells, and higher immune score in most immune-promoting pathways, including antigen processing and presentation, chemokines, interferons, and TNF-related pathways, alongside lower scores for the immune-suppressive TGF-β pathway. The gene discussed is TGFB1; the disease is neoplasm.